| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |